UPMC Lung and Mediastinal Oncology Course
This two-day conference aims to expand clinical knowledge and technical skill regarding management of cancers of the lung and mediastinum. Didactic sessions will be designed to feature world-renowned experts in lively pro/con debates and reveal their best technical pearls in “How I Do It” sessions. Important topics such as uni-portal vs. multi-portal video-assisted thoracoscopic surgery, the role of robotics in lung and mediastinal surgery, treatment options for non-small cell lung cancer, and node dissection will be explored in depth. The second day of the course will feature a broadcast of live surgery, including VATS lobectomy and robotic-assisted lobectomy.
Target Audience
This course is designed for thoracic surgeons, surgical oncologists, general surgeons, medical oncologists, radiation oncologists, internists, family practice providers, advanced practice providers, nurses, and any other associated health professionals with an interest in medical and surgical treatment for lung and mediastinal malignancies.
Learning Objectives
- In depth exploration of surgical and medical management strategies for lung and mediastinal cancers
- Consideration of the use of operations such as lobectomy, segementectomy for the management of lung cancer; and associated technical pearls
- Increased understanding of the advantages of having a robotic platform in your healthcare system can have for patients
- Primer on cutting-edge clinical trials for lung cancer
- Introduction into the future of early detection for lung cancer
Additional Information
Attachment | Size |
---|---|
SYS519684_2021_LM_OncCourse_Agenda_FNL_REV2_NC approved.pdf | 760.13 KB |
Thursday, April 8, 2021
Didactic Sessions
Microsoft Teams
7:30—7:35am: Welcome and Introduction
James D. Luketich, MD, FACS; Inderpal S. Sarkaria, MD, FACS; Matthew J. Schuchert, MD; FACS
SECTION I: Keynote Addresses
7:35—8:15am: Surgical Innovation at UPMC: MIS, Staplers, Robots & Beyond
James D. Luketich, MD, FACS
8:15—9:00am: Enhancing Functionality and Efficiency of the Thoracic Operating Room in the Era of Robotic Surgery
Mark R. Dylewski, MD
9:00—9:45am: Complex Resections for Locally Advanced Lung Cancer: Maximally Invasive Surgery
Garrett L. Walsh, MD
9:45—10:30am: Treatment of the High-Risk Lung Cancer Patient: SBRT, Surgery, PDT and Other Local Therapies
Hiran Chrishantha Fernando, MD, MPH
10:30—10:45am: Morning Break
SECTION II: Lung and Trachea I
Moderator: Matthew J. Schuchert, MD, FACS
10:45—11:05am: ECMO as an Adjunct in Advanced Airway Resection
Pablo Sanchez, MD , PhD, FACS
11:05—11:25am: Parenchymal-Sparing Lung Resections: When & Why
Matthew J. Schuchert, MD, FACS
11:25—11:45am Updates in Screening for Lung Cancer
David O. Wilson, MD, MPH
11:45—12:05pm: Lunch
SECTION III: Lung and Trachea II
Moderator: Lawrence Crist, DO, MBA
12:05—12:45pm: Robotic Bronchoscopy
Rajeev Dhupar, MD, MBA, FACS
12:45—1:05pm: New Advanced Intraoperative Imaging for Lung Cancer
Inderpal S. Sarkaria, MD, FACS
1:05—1:25pm: Afternoon break
1:25—2:00pm: Advances in Personalized Systemic Therapy for Advanced Lung Cancer
Antoinette Wozniak, MD
2:00—2:30pm: Surgeon’s Approach to Resectable Stage IIIA NSCLC
Ryan Levy, MD
SECTION V: Pleural & Mediastinal
Moderator: Inderpal S. Sarkaria, MD, FACS
2:30—3:00pm: Clinical Decision Making in Choosing Robotic Lobectomy and Technical Pearls
Mark R. Dylewski, MD
3:00—3:20pm: Thoracotomy or VATS or Robotic VATS: What is the Real Difference?
Garrett Walsh, MD
3:20—3:40pm: Robotic Approaches to Thymectomy
Inderpal S. Sarkaria, MD, FACS
3:40—4:00pm: Management of Malignant Mesothelioma
Neil A. Christie, MD
4:00—4:30pm: Final Question and Answer Panel
Moderator:
4:30pm: Didactic Adjourns
4:30—7:30pm: Exhibit Fair (Virtual)
Friday, April 9, 2021
Broadcast of Live Surgery
UPMC Presbyterian Hospital, Charles G Watson Surgical Education Center
7:30—8:00am: Welcome and Introduction
8:00—11:00am: Broadcast of Live Surgery
Moderator: Tadeusz D. Witek, MD
11:00-11:20am: Lunch
11:20-3:00pm: Resume Broadcast of Live Surgery
Moderator: Tadeusz D. Witek, MD
3:00pm: Course concludes
University of Pittsburgh Medical Center Course Directors:
James D. Luketich, MD, FACS
Henry T. Bahnson Professor of Cardiothoracic Surgery
Chairman, Department of Cardiothoracic Surgery
Chief, Division of General Thoracic and Foregut Surgery
UPMC Department of Cardiothoracic Surgery
Inderpal S. Sarkaria, MD, FACS
Vice Chairman, Clinical Affairs
Director, Thoracic Robotics
Co-Director, Esophageal and Lung Surgery Institute
UPMC Department of Cardiothoracic Surgery
Matthew J. Schuchert, MD, FACS
Associate Professor of Cardiothoracic Surgery
Program Director, Thoracic Surgery Independent Fellow and Integrated Residency Program
UPMC Department of Cardiothoracic Surgery
Invited Faculty:
Mark R. Dylewski, MD
Medical Director of Robotic and General Thoracic Surgery
Baptist Health of South Florida
Miami, Florida
Garrett L. Walsh, M.D.
Executive Director of Surgical Facilities Expansion
University of Texas, MD Anderson Cancer Center
Houston, Texas
Hiran Chrishantha Fernando, M.D.
Director, Thoracic Surgery
Allegheny General Hospital
Pittsburgh, Pennsylvania
Faculty Disclosure:
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
James D. Luketich, MD, FACS
Consultant: Medtronic
CE Speaker’s Bureau: Covidien
Stockholder: Intuitive Surgical, Inc.
Stockholder: Cigna Corp
Stockholder: Proctor & Gamble
Inderpal S. Sarkaria, MD, FACS
Grant/Research Support: On Target Laboratories
Consultant: Intuitive Surgical, Inc.
Consultant: Cambridge Medical Robotics
Consultant: Auris Medical
Mark R. Dylewski, MD
Consultant: Intuitive Surgical, Inc.
Consultant: J&J
CE Speakers’ Bureau: Auris Medical
Hiran C. Fernando, MBBS, FRCS, FACS, FRCSEd
CE Speakers’ Bureau: Boston Scientific
Merck – Steering Committee for Study
Antoinette Wozniak, MD
Consultant: Janssen
Consultant: GlaxoSmithKline
Consultant: Noovocure
Consultant: Epizyme
Consultant: Regeneron
Other: DSMB – BeyondSpring
Other: HUYA Pharmaceuticals
Other: Odonate Therapeutics
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation and Designation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 14.25 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 14.25 AAPA Category I CME
- 14.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 14.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 14.25 Attendance
We gratefully acknowledge support from the following for this activity:
Educational Grant:
Covidien LP, a Medtronic company
Exhibitors:
Auris Health, Inc.
BD
Medtronic
Ethicon US, LLC
Intuitive
Pinnacle Biologics, Inc.
Price
Registering online is the quickest and easiest way to reserve your space at CCEHS conferences.
• Visit our online registration at https://cce.upmc.com/upmc-lung-mediastinal-oncology-2021
• Click the Register/Complete Course button and enter all requested information
• After registering, an electronic confirmation will be sent to the email address you provided us when you registered.
For additional information, please contact Emily Burgardt at burgardte@upmc.edu.
Tuition for cancellations postmarked or date stamped before March 23rd, 2021, will be completely refunded. After March 23rd, 2021, a $30.00 administration fee will be assessed. No refunds will be made after April 1st, 2021. However, substitutes are welcome. Please notify Emily Burgardt at burgardte@upmc.edu of cancellations.